Label: SEEQUIN 2- hydroquinone liquid 

  • Label RSS
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated 11/13

If you are a consumer or patient please visit this version.

  • Active Ingredient

    Hydroquinone (2%)

    Close
  • Indication

    Skin Lightening

    Close
  • Indication

    To gradually lighten hyperpigmentation of the skin such as age spots, liver spots, freckles, or other areas of unwanted melanin hyperpigmentation that may occur in pregnancy or from the use of oral contraceptives.

    Close
  • Precautions

    For external use only. A mild transient stinging may occur for people with sensitive skin. Do not use on broken or irritated skin. Discontinue use if irritation or rash occurs. Avoid contact with eyes and mucous membranes. In case of contact, rinse thoroughly with water. Do not use on children under 12 years of age. Keep out of reach of children. Avoid use around the eyes and lips.

    Close
  • Precautions

    keep away from children.

    Close
  • Directions

    Remove and discard solid white cap from bottle and replace with dropper cap. Test for skin sensitivity before using by applying 1 or 2 drops of SEEQUIN™ 2 IDS™ Liquid Gel S-erum * to an area of unbroken skin about 25 mm in diameter. If excessive irritation, rash or other reaction develops within 24 hours, discontinue use. To apply, place 1 to 2 drops of SEEQUIN™ 2 IDS™ Liquid Gel S-erum* in the palm of your hand and use fingertips to apply a thin layer to the affected areas. Use both morning and night or as directed by a physician. Depigmentation is a gradual process and results should be expected within 12 weeks of daily use. Discontinue use if no results are apparent after 8 weeks. To maintain results, use several times per week or as directed by a physician. Limit sun exposure during treatment by using protective clothing or a sunscreen protective agent to avoid re-darkening of the skin. Close dropper cap securely after each use. Store at room temperature (15-25°C / 59-77°F).

    Close
  • Non-Medicinal Ingredients

    CITRUS GRANDIS (GRAPEFRUIT) EXTRACT, ETHOXYDIGLYCOL, FRAGRANCE/ PARFUM, L-ASCORBIC ACID USP, PROPYLENE GLYCOL, WATER/EAU.

    Close
  • Principal Display Panel

    Seequin2__PackageLabel_PrincipalDisplayPanel

    Seequin2__PackageLabel_PrincipalDisplayPanel

    Close
  • INGREDIENTS AND APPEARANCE
    SEEQUIN 2 
    hydroquinone liquid
    Product Information
    Product Type HUMAN OTC DRUG LABEL Item Code (Source) NDC:67226-2620
    Route of Administration TOPICAL DEA Schedule     
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 2 g  in 100 mL
    Inactive Ingredients
    Ingredient Name Strength
    GRAPEFRUIT  
    DIETHYLENE GLYCOL MONOETHYL ETHER  
    ASCORBIC ACID  
    PROPYLENE GLYCOL  
    WATER  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:67226-2620-3 1 in 1 BOX
    1 30 mL in 1 BOTTLE, DROPPER
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC monograph not final part358A 09/01/2013
    Labeler - Vivier Pharma, Inc. (250996550)
    Establishment
    Name Address ID/FEI Business Operations
    Vivier Pharma, Inc. 250996550 manufacture(67226-2620)
    Close